ORMP
ORAMED PHARMACEUTICALS INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
ORAMED PHARMACEUTICALS INC (ORMP) is held by 4 tracked hedge-fund managers, a combined reported value of ~$1.03M; the largest are Renaissance Technologies, Ken Griffin, Steven Cohen. This quarter: 1 new, 1 added, 1 trimmed. 4 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding4
Congress trades4
Price$4.03vs quarter-end+18.53%
Sectors0
This quarter's moves
Top holderRenaissance TechnologiesNew1
Added1
Trimmed / sold1
Value $502.2K0.0% of portfolio147,7002026 Q1
Value $51.3K— of portfolio22,8002025 Q2
Value $428— of portfolio2002025 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Renaissance Technologies | $502.2K | 0.0% | Hold |
| Ken GriffinCALL | $51.3K | — | — |
| Ken GriffinPUT | $428 | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.